Medscape Medical News, November 14, 2020 EURETINA 2020 Changes to Anti-VEGF Protocols ... loss in neovascular age-related macular degeneration. Medscape Medical News, October 14, 2020 EURETINA ...

The FDA has started a review of a new implant version of Roche's ranibizumab therapy for wet age-related macular degeneration ... on the application by October 23, barring any delays.

Prospects for Novartis' ophthalmology drug Beovu have taken another dive after the drugmaker reported toxicity issues in a new phase 3 trial in wet age-related macular degeneration (AMD).

The investigators retrospectively evaluated 126 consecutive treatment-naïve nAMD patients (126 eyes) who received a loading ...

Neovascularization is responsible for severe vision loss in patients with age-related macular degeneration (AMD ... vascular endothelial growth factor (VEGF), which promotes angiogenesis.

Regeneron Pharmaceuticals, Inc. faces Eylea revenue decline but shows growth potential with Dupixent & Libtayo. Click for ...

This article will explain why eye screenings are crucial, how diabetic retinopathy develops, and what you can do to protect ...

As a former claims handler and fraud investigator, Jason Metz has worked on a multitude of complex and multifaceted claims. The insurance industry can be seemingly opaque, and Jason enjoys ...

Hi, %{firstName}% Games Car rental You can ward off plenty of health conditions by looking out for early warning signs, but there are no such indications in the early stages of age-related macular ...